Metformin Vitabalans (Metformin Hydrochloride)

Metformin Hydrochloride activates AMP‑activated protein kinase (AMPK), which suppresses liver glucose output, decreases intestinal glucose absorption, and enhances peripheral tissue uptake of glucose. This combined action improves overall glycaemic control without stimulating insulin release.

The dosage of Metformin Vitabalans is individualized by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. The prescriber determines the appropriate strength, frequency, and titration schedule.

Metformin may be used during pregnancy when the benefits outweigh potential risks, such as in gestational diabetes, but it should be prescribed by a qualified obstetrician. Limited data exist for breastfeeding; the decision should be made by the healthcare provider after evaluating infant exposure.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with sulfonylureas, Metformin does not cause insulin‑mediated hypoglycaemia and often leads to modest weight loss. Unlike insulin, it is oral and does not require injection. It is frequently used as first‑line therapy because of its efficacy, safety profile, and cardiovascular benefits.

Metformin Vitabalans should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Metformin Vitabalans is taken orally, usually with meals to minimise gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition, especially in patients with severe renal or hepatic impairment. Other serious concerns include severe skin reactions and vitamin B12 deficiency with long‑term use.

Metformin Vitabalans is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and those receiving radiographic contrast agents unless renal function is re‑evaluated afterward.